Your browser doesn't support javascript.
loading
Cancer microenvironment and genomics: evolution in process.
Leong, Stanley P; Witz, Isaac P; Sagi-Assif, Orit; Izraely, Sivan; Sleeman, Jonathan; Piening, Brian; Fox, Bernard A; Bifulco, Carlo B; Martini, Rachel; Newman, Lisa; Davis, Melissa; Sanders, Lauren M; Haussler, David; Vaske, Olena M; Witte, Marlys.
Afiliação
  • Leong SP; California Pacific Medical Center and Research Institute, San Francisco, USA.
  • Witz IP; The Shmunis School of Biomedicine and Cancer Research, School of Molecular Cell Biology & Biotechnology, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.
  • Sagi-Assif O; The Shmunis School of Biomedicine and Cancer Research, School of Molecular Cell Biology & Biotechnology, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.
  • Izraely S; The Shmunis School of Biomedicine and Cancer Research, School of Molecular Cell Biology & Biotechnology, George S. Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel.
  • Sleeman J; European Center for Angioscience, Medizinische Fakultät Mannheim der Universität Heidelberg, Heidelberg, Germany.
  • Piening B; Providence Portland Medical Center, Portland, USA.
  • Fox BA; Providence Portland Medical Center, Portland, USA.
  • Bifulco CB; Providence Portland Medical Center, Portland, USA.
  • Martini R; Department of Surgery, Weill Cornell Medical College, New York City, NY, USA.
  • Newman L; Department of Genetics, University of Georgia, Athens, GA, USA.
  • Davis M; Department of Surgery, Weill Cornell Medical College, New York City, NY, USA.
  • Sanders LM; Department of Surgery, Weill Cornell Medical College, New York City, NY, USA. mbd4001@med.cornell.edu.
  • Haussler D; Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz and UC Santa Cruz Genomics Institute, Santa Cruz, USA.
  • Vaske OM; UC Santa Cruz Genomics Institute and Howard Hughes Medical Institute, University of California Santa Cruz, Santa Cruz, USA. haussler@ucsc.edu.
  • Witte M; Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz and UC Santa Cruz Genomics Institute, Santa Cruz, USA.
Clin Exp Metastasis ; 39(1): 85-99, 2022 02.
Article em En | MEDLINE | ID: mdl-33970362
ABSTRACT
Cancer heterogeneity is a result of genetic mutations within the cancer cells. Their proliferation is not only driven by autocrine functions but also under the influence of cancer microenvironment, which consists of normal stromal cells such as infiltrating immune cells, cancer-associated fibroblasts, endothelial cells, pericytes, vascular and lymphatic channels. The relationship between cancer cells and cancer microenvironment is a critical one and we are just on the verge to understand it on a molecular level. Cancer microenvironment may serve as a selective force to modulate cancer cells to allow them to evolve into more aggressive clones with ability to invade the lymphatic or vascular channels to spread to regional lymph nodes and distant sites. It is important to understand these steps of cancer evolution within the cancer microenvironment towards invasion so that therapeutic strategies can be developed to control or stop these processes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Neoplasias Limite: Humans Idioma: En Revista: Clin Exp Metastasis Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Neoplasias Limite: Humans Idioma: En Revista: Clin Exp Metastasis Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos